Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 19

1.

Inhibition of MMP-3 or -9 suppresses lipopolysaccharide-induced expression of proinflammatory cytokines and iNOS in microglia.

Woo MS, Park JS, Choi IY, Kim WK, Kim HS.

J Neurochem. 2008 Jul;106(2):770-80. doi: 10.1111/j.1471-4159.2008.05430.x. Epub 2008 Apr 17.

2.

Regulation of matrix metalloproteinase expressions in astrocytes, microglia and neurons.

Gottschall PE, Deb S.

Neuroimmunomodulation. 1996 Mar-Jun;3(2-3):69-75. Review.

PMID:
8945720
3.

Microglial activation and its implications in the brain diseases.

Dheen ST, Kaur C, Ling EA.

Curr Med Chem. 2007;14(11):1189-97. Review.

PMID:
17504139
4.

Emerging features in the regulation of MMP-9 gene expression for the development of novel molecular targets and therapeutic strategies.

St-Pierre Y, Van Themsche C, Estève PO.

Curr Drug Targets Inflamm Allergy. 2003 Sep;2(3):206-15. Review.

PMID:
14561155
5.

Role of cytokines in inflammatory process in Parkinson's disease.

Sawada M, Imamura K, Nagatsu T.

J Neural Transm Suppl. 2006;(70):373-81. Review.

PMID:
17017556
6.

The role of microglial mtDNA damage in age-dependent prolonged LPS-induced sickness behavior.

Nakanishi H, Hayashi Y, Wu Z.

Neuron Glia Biol. 2011 Feb;7(1):17-23. doi: 10.1017/S1740925X1100010X. Epub 2011 Oct 28. Review.

PMID:
22032249
7.

Mechanisms of inflammatory neurodegeneration: iNOS and NADPH oxidase.

Brown GC.

Biochem Soc Trans. 2007 Nov;35(Pt 5):1119-21. Review.

PMID:
17956292
9.

Roles of glia-derived cytokines on neuronal degeneration and regeneration.

Suzumura A, Takeuchi H, Zhang G, Kuno R, Mizuno T.

Ann N Y Acad Sci. 2006 Nov;1088:219-29. Review.

PMID:
17192568
10.

Molecular mechanism for activation and regulation of matrix metalloproteinases during bacterial infections and respiratory inflammation.

Okamoto T, Akuta T, Tamura F, van Der Vliet A, Akaike T.

Biol Chem. 2004 Nov;385(11):997-1006. Review.

PMID:
15576319
11.

Metalloproteinases and atherothrombosis: MMP-10 mediates vascular remodeling promoted by inflammatory stimuli.

Rodriguez JA, Orbe J, Martinez de Lizarrondo S, Calvayrac O, Rodriguez C, Martinez-Gonzalez J, Paramo JA.

Front Biosci. 2008 Jan 1;13:2916-21. Review.

PMID:
17981764
12.

Cytotoxicity of microglia.

Banati RB, Gehrmann J, Schubert P, Kreutzberg GW.

Glia. 1993 Jan;7(1):111-8. Review.

PMID:
8423058
13.

Therapeutic potential of matrix metalloprotease inhibitors in neuropathic pain.

Dev R, Srivastava PK, Iyer JP, Dastidar SG, Ray A.

Expert Opin Investig Drugs. 2010 Apr;19(4):455-68. doi: 10.1517/13543781003643486. Review.

PMID:
20218929
14.

Microglial signal transduction as a target of alcohol action in the brain.

Suk K.

Curr Neurovasc Res. 2007 May;4(2):131-42. Review.

PMID:
17504211
15.

Role of matrix metalloproteinase-3 in neurodegeneration.

Kim EM, Hwang O.

J Neurochem. 2011 Jan;116(1):22-32. doi: 10.1111/j.1471-4159.2010.07082.x. Epub 2010 Dec 2. Review.

16.

Immortalized human microglial cell line: phenotypic expression.

Nagai A, Mishima S, Ishida Y, Ishikura H, Harada T, Kobayashi S, Kim SU.

J Neurosci Res. 2005 Aug 1;81(3):342-8. Review.

PMID:
15957187
17.

Microglial activation and matrix protease generation during focal cerebral ischemia.

del Zoppo GJ, Milner R, Mabuchi T, Hung S, Wang X, Berg GI, Koziol JA.

Stroke. 2007 Feb;38(2 Suppl):646-51. Review.

18.

[The microglia hypothesis of psychiatric disorders].

Monji A.

Nihon Shinkei Seishin Yakurigaku Zasshi. 2011 Feb;31(1):1-8. Review. Japanese.

PMID:
21409839
19.

Matrix metalloproteinase dependent cleavage of cell adhesion molecules in the pathogenesis of CNS dysfunction with HIV and methamphetamine.

Conant K, Lim ST, Randall B, Maguire-Zeiss KA.

Curr HIV Res. 2012 Jul;10(5):384-91. Review.

PMID:
22591362

Supplemental Content

Support Center